Data presented may shift the treatment paradigm to 2-drug regimens (2DRs) for people living with HIV ... Oct 01
Lupin announced today the launch of Lapatinib Tablets, 250 mg, after Lupin’s alliance partner Natco Pharma Ltd received final approval for its ANDA from ... Sep 30
RAIN-32 is a potent and selective MDM2 inhibitor that has been evaluated in clinical trials for solid tumors and hematologic malignancies... Sep 03
-Advertisements-